

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.59480829 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59480829 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.26538283 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26538283 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.81048764 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.52645428 |
| 7 | exogenous drug catabolic process (GO:0042738) | 6.46855934 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.11928140 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.11928140 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.11928140 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.02293968 |
| 12 | epoxygenase P450 pathway (GO:0019373) | 6.00006410 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.96224361 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.85865642 |
| 15 | regulation of plasminogen activation (GO:0010755) | 5.82759420 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.76684500 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.76660573 |
| 18 | urea cycle (GO:0000050) | 5.71070094 |
| 19 | urea metabolic process (GO:0019627) | 5.71070094 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61826692 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 5.61262480 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45443627 |
| 23 | protein carboxylation (GO:0018214) | 5.45443627 |
| 24 | omega-hydroxylase P450 pathway (GO:0097267) | 5.41200011 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.40070361 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.38835792 |
| 27 | cysteine metabolic process (GO:0006534) | 5.37885474 |
| 28 | complement activation, alternative pathway (GO:0006957) | 5.37246719 |
| 29 | * negative regulation of fibrinolysis (GO:0051918) | 5.32469889 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.24895774 |
| 31 | * regulation of fibrinolysis (GO:0051917) | 5.23629698 |
| 32 | negative regulation of protein activation cascade (GO:2000258) | 5.20476398 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.14132281 |
| 34 | bile acid metabolic process (GO:0008206) | 5.09917995 |
| 35 | reverse cholesterol transport (GO:0043691) | 5.07240948 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 5.04362740 |
| 37 | regulation of apoptotic cell clearance (GO:2000425) | 5.03954404 |
| 38 | regulation of complement activation (GO:0030449) | 5.02658099 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.95178703 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.94486102 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.94486102 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.94486102 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.94182909 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87810267 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.82911450 |
| 46 | regulation of humoral immune response (GO:0002920) | 4.79051127 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.76305042 |
| 48 | phospholipid efflux (GO:0033700) | 4.73826989 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.70809233 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.70809233 |
| 51 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.67194360 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.64296864 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.63820047 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.63820047 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.62262366 |
| 56 | lysine metabolic process (GO:0006553) | 4.57027418 |
| 57 | lysine catabolic process (GO:0006554) | 4.57027418 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.55012710 |
| 59 | * negative regulation of hemostasis (GO:1900047) | 4.54861110 |
| 60 | * negative regulation of blood coagulation (GO:0030195) | 4.54861110 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.52856580 |
| 62 | glycine metabolic process (GO:0006544) | 4.44484088 |
| 63 | ethanol metabolic process (GO:0006067) | 4.42165186 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.40444810 |
| 65 | cholesterol efflux (GO:0033344) | 4.35607891 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.34225048 |
| 67 | coenzyme catabolic process (GO:0009109) | 4.34021619 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.33961851 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.27365447 |
| 70 | drug metabolic process (GO:0017144) | 4.26971013 |
| 71 | glutamate metabolic process (GO:0006536) | 4.25212422 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.24576398 |
| 73 | amine catabolic process (GO:0009310) | 4.24576398 |
| 74 | cellular glucuronidation (GO:0052695) | 4.22766918 |
| 75 | negative regulation of complement activation (GO:0045916) | 4.21277997 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.19250298 |
| 77 | * negative regulation of coagulation (GO:0050819) | 4.15527851 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 4.14768959 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 4.12291947 |
| 80 | fibrinolysis (GO:0042730) | 4.11798712 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.09637351 |
| 82 | ethanol oxidation (GO:0006069) | 4.06733090 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 4.06701629 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06479301 |
| 85 | arginine metabolic process (GO:0006525) | 4.05989231 |
| 86 | * negative regulation of wound healing (GO:0061045) | 4.05306628 |
| 87 | aldehyde catabolic process (GO:0046185) | 4.05228107 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 4.04991221 |
| 89 | ketone body metabolic process (GO:1902224) | 3.92106838 |
| 90 | * positive regulation of hemostasis (GO:1900048) | 3.90802938 |
| 91 | * positive regulation of blood coagulation (GO:0030194) | 3.90802938 |
| 92 | drug catabolic process (GO:0042737) | 3.88611007 |
| 93 | oxidative demethylation (GO:0070989) | 3.87271133 |
| 94 | negative regulation of lipase activity (GO:0060192) | 3.82802692 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.82710959 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.82271539 |
| 97 | cofactor catabolic process (GO:0051187) | 3.80934654 |
| 98 | phenylpropanoid metabolic process (GO:0009698) | 3.80823822 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.80341962 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80237167 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.78113057 |
| 102 | plasma lipoprotein particle organization (GO:0071827) | 3.75899016 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.74971954 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.74971954 |
| 105 | complement activation (GO:0006956) | 3.74649173 |
| 106 | organic acid catabolic process (GO:0016054) | 3.74043016 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 3.74043016 |
| 108 | sterol homeostasis (GO:0055092) | 3.73984983 |
| 109 | protein-lipid complex assembly (GO:0065005) | 3.71799709 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.70384187 |
| 111 | cytolysis (GO:0019835) | 3.67230890 |
| 112 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66870363 |
| 113 | * protein activation cascade (GO:0072376) | 3.66132942 |
| 114 | short-chain fatty acid metabolic process (GO:0046459) | 3.64627275 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 3.63307597 |
| 116 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.62245828 |
| 117 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.61886608 |
| 118 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.61886608 |
| 119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.61711269 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.60541490 |
| 121 | * positive regulation of coagulation (GO:0050820) | 3.56758725 |
| 122 | NAD biosynthetic process (GO:0009435) | 3.54964519 |
| 123 | intestinal absorption (GO:0050892) | 3.53904930 |
| 124 | acute inflammatory response (GO:0002526) | 3.53639664 |
| 125 | protein-lipid complex subunit organization (GO:0071825) | 3.53456867 |
| 126 | acute-phase response (GO:0006953) | 3.53147476 |
| 127 | cholesterol transport (GO:0030301) | 3.53112319 |
| 128 | sterol transport (GO:0015918) | 3.53112319 |
| 129 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.51969420 |
| 130 | proline metabolic process (GO:0006560) | 3.47713869 |
| 131 | response to mercury ion (GO:0046689) | 3.44000158 |
| 132 | doxorubicin metabolic process (GO:0044598) | 3.41685316 |
| 133 | daunorubicin metabolic process (GO:0044597) | 3.41685316 |
| 134 | polyketide metabolic process (GO:0030638) | 3.41685316 |
| 135 | positive regulation of extracellular matrix organization (GO:1903055) | 3.39203260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39624835 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21622402 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.05552533 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51555483 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29490613 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.09178359 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.86657718 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03491767 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03321200 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07865946 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00802398 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0590380 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96463264 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79338896 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59911130 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57145255 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53962507 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46940092 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40128897 |
| 20 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.30026377 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29072024 |
| 22 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.19439434 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18756812 |
| 24 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18472791 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18103551 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16238439 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12427992 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00694646 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00296047 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96500463 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93211451 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89362529 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88519336 |
| 34 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88216803 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85881196 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85537203 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83758099 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83448340 |
| 39 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83300848 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83004089 |
| 41 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.82101197 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81745122 |
| 43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79738717 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79648742 |
| 45 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78233018 |
| 46 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76613278 |
| 47 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.76490461 |
| 48 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75785365 |
| 49 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.75618179 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75377432 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75198849 |
| 52 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74807002 |
| 53 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.71728066 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71462310 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71454915 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.70485028 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70107584 |
| 58 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.69920593 |
| 59 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.66953805 |
| 60 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.66776990 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66651457 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66135663 |
| 63 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.64539677 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.63796602 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63752085 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63445874 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63445874 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62921653 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62907984 |
| 70 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61858142 |
| 71 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.61707006 |
| 72 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61542441 |
| 73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60624538 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59762862 |
| 75 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.58189549 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.57712520 |
| 77 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.57506532 |
| 78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57489247 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.56646410 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.56464557 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55208948 |
| 82 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.54952703 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.54084553 |
| 84 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.54057654 |
| 85 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.53326774 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53141867 |
| 87 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.52879293 |
| 88 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.52723874 |
| 89 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52592643 |
| 90 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52460582 |
| 91 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.52437345 |
| 92 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.52138661 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51930707 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51392680 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50918432 |
| 96 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.50459916 |
| 97 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.50437234 |
| 98 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50095704 |
| 99 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.49849331 |
| 100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.49828139 |
| 101 | TP53_16413492_ChIP-PET_HCT116_Human | 0.49233679 |
| 102 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.49008331 |
| 103 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.48694238 |
| 104 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48510219 |
| 105 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.48213586 |
| 106 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47976843 |
| 107 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.47746624 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47633804 |
| 109 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46972772 |
| 110 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46820969 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46288874 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45357541 |
| 113 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45303313 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44816204 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43531700 |
| 116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43442250 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.42635479 |
| 118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42626947 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41265249 |
| 120 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41000263 |
| 121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40786764 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40362426 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40029149 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39156443 |
| 125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39128983 |
| 126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38847023 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38051087 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37972351 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37795250 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37573481 |
| 131 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36030495 |
| 132 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34733966 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34588638 |
| 134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34056099 |
| 135 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33662584 |
| 136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33637824 |
| 137 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.33109383 |
| 138 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33057096 |
| 139 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.32620874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.31738429 |
| 2 | MP0005360_urolithiasis | 7.53267760 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43511010 |
| 4 | MP0005365_abnormal_bile_salt | 6.18663893 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.09045059 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26925753 |
| 7 | MP0003252_abnormal_bile_duct | 3.89071839 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.63473442 |
| 9 | MP0009840_abnormal_foam_cell | 3.36619079 |
| 10 | MP0005083_abnormal_biliary_tract | 3.10520318 |
| 11 | MP0003195_calcinosis | 2.81626203 |
| 12 | MP0005332_abnormal_amino_acid | 2.74894008 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58649935 |
| 14 | MP0003122_maternal_imprinting | 2.52340128 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.41617186 |
| 16 | MP0000609_abnormal_liver_physiology | 2.17817692 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.12798478 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.10670494 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.96864536 |
| 20 | MP0003868_abnormal_feces_composition | 1.92734613 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.82700353 |
| 22 | MP0001764_abnormal_homeostasis | 1.69064748 |
| 23 | MP0009697_abnormal_copulation | 1.64353974 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57671569 |
| 25 | MP0001915_intracranial_hemorrhage | 1.49720320 |
| 26 | MP0003011_delayed_dark_adaptation | 1.46122957 |
| 27 | MP0005451_abnormal_body_composition | 1.45048651 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.33466575 |
| 29 | MP0000566_synostosis | 1.31064934 |
| 30 | MP0003186_abnormal_redox_activity | 1.27345021 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.23022206 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.22016111 |
| 33 | MP0003123_paternal_imprinting | 1.21091984 |
| 34 | MP0000598_abnormal_liver_morphology | 1.18773430 |
| 35 | MP0002089_abnormal_postnatal_growth/wei | 1.17347604 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.15308919 |
| 37 | MP0005647_abnormal_sex_gland | 1.13056332 |
| 38 | MP0000604_amyloidosis | 1.12560957 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.10307274 |
| 40 | MP0009764_decreased_sensitivity_to | 1.05534596 |
| 41 | MP0002254_reproductive_system_inflammat | 1.03637065 |
| 42 | MP0009763_increased_sensitivity_to | 1.02653286 |
| 43 | MP0010368_abnormal_lymphatic_system | 0.99368675 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 0.93168510 |
| 45 | MP0008469_abnormal_protein_level | 0.89412018 |
| 46 | * MP0009642_abnormal_blood_homeostasis | 0.86537574 |
| 47 | MP0005408_hypopigmentation | 0.85123041 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.82518943 |
| 49 | MP0005376_homeostasis/metabolism_phenot | 0.81017111 |
| 50 | MP0009765_abnormal_xenobiotic_induced | 0.78528753 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.78009590 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 0.76933336 |
| 53 | MP0002876_abnormal_thyroid_physiology | 0.75219656 |
| 54 | MP0005670_abnormal_white_adipose | 0.74871988 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.71715958 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 0.71273800 |
| 57 | MP0002971_abnormal_brown_adipose | 0.70757201 |
| 58 | MP0005409_darkened_coat_color | 0.70230515 |
| 59 | MP0003879_abnormal_hair_cell | 0.68849803 |
| 60 | MP0004130_abnormal_muscle_cell | 0.68547421 |
| 61 | MP0005334_abnormal_fat_pad | 0.67990401 |
| 62 | MP0003690_abnormal_glial_cell | 0.67922135 |
| 63 | MP0009053_abnormal_anal_canal | 0.67294706 |
| 64 | MP0001661_extended_life_span | 0.66947601 |
| 65 | MP0005535_abnormal_body_temperature | 0.66409570 |
| 66 | MP0005266_abnormal_metabolism | 0.64672292 |
| 67 | MP0003329_amyloid_beta_deposits | 0.63795104 |
| 68 | MP0004272_abnormal_basement_membrane | 0.63780379 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.62585559 |
| 70 | MP0001756_abnormal_urination | 0.58076316 |
| 71 | MP0002282_abnormal_trachea_morphology | 0.57731403 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.57543983 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 0.56537180 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.56494614 |
| 75 | MP0005448_abnormal_energy_balance | 0.55394931 |
| 76 | MP0006054_spinal_hemorrhage | 0.54790148 |
| 77 | MP0003121_genomic_imprinting | 0.54788304 |
| 78 | MP0005257_abnormal_intraocular_pressure | 0.50116403 |
| 79 | MP0002909_abnormal_adrenal_gland | 0.49994871 |
| 80 | MP0002822_catalepsy | 0.49075492 |
| 81 | MP0005395_other_phenotype | 0.48804451 |
| 82 | MP0005023_abnormal_wound_healing | 0.48752964 |
| 83 | MP0003718_maternal_effect | 0.45970651 |
| 84 | MP0003638_abnormal_response/metabolism_ | 0.45305949 |
| 85 | MP0008874_decreased_physiological_sensi | 0.45112370 |
| 86 | MP0008873_increased_physiological_sensi | 0.44758071 |
| 87 | MP0005187_abnormal_penis_morphology | 0.44430794 |
| 88 | MP0002928_abnormal_bile_duct | 0.44023494 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.43960305 |
| 90 | MP0003632_abnormal_nervous_system | 0.43836445 |
| 91 | MP0003436_decreased_susceptibility_to | 0.42224633 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.41981477 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.41650133 |
| 94 | MP0003075_altered_response_to | 0.41629757 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 0.41506892 |
| 96 | MP0000920_abnormal_myelination | 0.41408747 |
| 97 | MP0003724_increased_susceptibility_to | 0.40586286 |
| 98 | MP0003953_abnormal_hormone_level | 0.40394458 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.39967043 |
| 100 | MP0003950_abnormal_plasma_membrane | 0.38657904 |
| 101 | MP0005248_abnormal_Harderian_gland | 0.38460399 |
| 102 | MP0002933_joint_inflammation | 0.38381683 |
| 103 | MP0004381_abnormal_hair_follicle | 0.38171482 |
| 104 | MP0005166_decreased_susceptibility_to | 0.38098089 |
| 105 | MP0008872_abnormal_physiological_respon | 0.38036402 |
| 106 | MP0009672_abnormal_birth_weight | 0.37108772 |
| 107 | MP0001324_abnormal_eye_pigmentation | 0.36757247 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.36264053 |
| 109 | MP0003878_abnormal_ear_physiology | 0.35975896 |
| 110 | MP0005377_hearing/vestibular/ear_phenot | 0.35975896 |
| 111 | MP0004883_abnormal_blood_vessel | 0.34737617 |
| 112 | MP0005379_endocrine/exocrine_gland_phen | 0.34094069 |
| 113 | MP0000249_abnormal_blood_vessel | 0.33220242 |
| 114 | MP0002796_impaired_skin_barrier | 0.33114841 |
| 115 | MP0000003_abnormal_adipose_tissue | 0.33049786 |
| 116 | MP0000579_abnormal_nail_morphology | 0.32939069 |
| 117 | MP0001243_abnormal_dermal_layer | 0.32507731 |
| 118 | MP0009115_abnormal_fat_cell | 0.32440083 |
| 119 | MP0006082_CNS_inflammation | 0.31688536 |
| 120 | MP0003633_abnormal_nervous_system | 0.31495723 |
| 121 | MP0001270_distended_abdomen | 0.31331005 |
| 122 | MP0005410_abnormal_fertilization | 0.30917656 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.30703638 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.30155420 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.29951289 |
| 126 | MP0003631_nervous_system_phenotype | 0.29894259 |
| 127 | MP0002168_other_aberrant_phenotype | 0.29813563 |
| 128 | MP0002970_abnormal_white_adipose | 0.29727692 |
| 129 | MP0001853_heart_inflammation | 0.29580130 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.28991634 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.28350997 |
| 132 | MP0003941_abnormal_skin_development | 0.28153681 |
| 133 | MP0002128_abnormal_blood_circulation | 0.28042070 |
| 134 | MP0002249_abnormal_larynx_morphology | 0.27524929 |
| 135 | MP0001881_abnormal_mammary_gland | 0.27127139 |
| 136 | MP0005164_abnormal_response_to | 0.26986993 |
| 137 | MP0002132_abnormal_respiratory_system | 0.25933335 |
| 138 | MP0002090_abnormal_vision | 0.23755331 |
| 139 | MP0002060_abnormal_skin_morphology | 0.22558442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.53358450 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.39142602 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.30421024 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.67001326 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64532434 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.47484557 |
| 7 | Xanthomatosis (HP:0000991) | 6.33199633 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.60148472 |
| 9 | Complement deficiency (HP:0004431) | 5.38713135 |
| 10 | Joint hemorrhage (HP:0005261) | 4.90649658 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.89321735 |
| 12 | Hyperammonemia (HP:0001987) | 4.60957201 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.55687648 |
| 14 | Epidermoid cyst (HP:0200040) | 4.47935725 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.46574420 |
| 16 | Hyperglycinemia (HP:0002154) | 4.38979952 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.30741200 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.29555040 |
| 19 | Ketosis (HP:0001946) | 4.24578041 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23205963 |
| 21 | Fat malabsorption (HP:0002630) | 4.11693719 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11461870 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.10468459 |
| 24 | Abnormality of complement system (HP:0005339) | 3.93344610 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.87770870 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87729073 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.87729073 |
| 28 | Hyperglycinuria (HP:0003108) | 3.87037630 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83298544 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.82653838 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.67134980 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.63412873 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.37054094 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35416881 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32805488 |
| 36 | Spontaneous abortion (HP:0005268) | 3.13507048 |
| 37 | Purpura (HP:0000979) | 3.09953918 |
| 38 | Steatorrhea (HP:0002570) | 3.09324239 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.07480540 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.07313928 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.05912108 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03595284 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.02195637 |
| 44 | Ketoacidosis (HP:0001993) | 2.97613101 |
| 45 | Myocardial infarction (HP:0001658) | 2.90776671 |
| 46 | Metabolic acidosis (HP:0001942) | 2.76314890 |
| 47 | Skin nodule (HP:0200036) | 2.76308677 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.71531077 |
| 49 | Osteomalacia (HP:0002749) | 2.67055822 |
| 50 | Acanthocytosis (HP:0001927) | 2.66409199 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.63743654 |
| 52 | Lethargy (HP:0001254) | 2.59391895 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.57146652 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57146652 |
| 55 | Vascular calcification (HP:0004934) | 2.55658275 |
| 56 | Abnormal gallbladder morphology (HP:0012437) | 2.50776589 |
| 57 | Glomerulonephritis (HP:0000099) | 2.49122460 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.48402467 |
| 59 | Arthropathy (HP:0003040) | 2.45072488 |
| 60 | Cholelithiasis (HP:0001081) | 2.44975326 |
| 61 | Spastic diplegia (HP:0001264) | 2.44602628 |
| 62 | Cerebral edema (HP:0002181) | 2.42773170 |
| 63 | Abnormal gallbladder physiology (HP:0012438) | 2.41812696 |
| 64 | Cholecystitis (HP:0001082) | 2.41812696 |
| 65 | Gout (HP:0001997) | 2.40890758 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38529453 |
| 67 | Amyloidosis (HP:0011034) | 2.38342271 |
| 68 | Mitral stenosis (HP:0001718) | 2.38015298 |
| 69 | Abnormal tarsal ossification (HP:0008369) | 2.36991025 |
| 70 | Abnormality of carpal bone ossification (HP:0006257) | 2.35380259 |
| 71 | Neonatal onset (HP:0003623) | 2.33972405 |
| 72 | Irritability (HP:0000737) | 2.33776341 |
| 73 | Gingival bleeding (HP:0000225) | 2.29584903 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.26599663 |
| 75 | Malnutrition (HP:0004395) | 2.24621175 |
| 76 | Esophageal varix (HP:0002040) | 2.22166116 |
| 77 | Pulmonary embolism (HP:0002204) | 2.20037966 |
| 78 | Menorrhagia (HP:0000132) | 2.19651524 |
| 79 | Pancreatitis (HP:0001733) | 2.14984761 |
| 80 | Thrombophlebitis (HP:0004418) | 2.13990784 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.12341988 |
| 82 | Enlarged kidneys (HP:0000105) | 2.11578089 |
| 83 | Poikilocytosis (HP:0004447) | 2.11432411 |
| 84 | Brushfield spots (HP:0001088) | 2.10661594 |
| 85 | Late onset (HP:0003584) | 2.09406556 |
| 86 | Increased serum pyruvate (HP:0003542) | 2.07776192 |
| 87 | Vomiting (HP:0002013) | 2.05915827 |
| 88 | Abnormality of the gallbladder (HP:0005264) | 2.03026920 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.02040801 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01170821 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.00252167 |
| 92 | Opisthotonus (HP:0002179) | 2.00233757 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.99172152 |
| 94 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96677494 |
| 95 | Broad alveolar ridges (HP:0000187) | 1.92425080 |
| 96 | Rickets (HP:0002748) | 1.92326340 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.92043699 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 1.91988156 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88831239 |
| 100 | Bifid scrotum (HP:0000048) | 1.88224620 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 1.86887240 |
| 102 | Abnormality of glycolysis (HP:0004366) | 1.86534502 |
| 103 | Renal cortical cysts (HP:0000803) | 1.84596421 |
| 104 | Facial shape deformation (HP:0011334) | 1.84489774 |
| 105 | Potter facies (HP:0002009) | 1.84489774 |
| 106 | Flat acetabular roof (HP:0003180) | 1.83648819 |
| 107 | Hypophosphatemic rickets (HP:0004912) | 1.83133675 |
| 108 | Joint swelling (HP:0001386) | 1.82915184 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.82156830 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 1.82156830 |
| 111 | Elevated hepatic transaminases (HP:0002910) | 1.80994363 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79120209 |
| 113 | Alkalosis (HP:0001948) | 1.78058428 |
| 114 | Epistaxis (HP:0000421) | 1.77789954 |
| 115 | Status epilepticus (HP:0002133) | 1.77599366 |
| 116 | Nephritis (HP:0000123) | 1.76230559 |
| 117 | Small epiphyses (HP:0010585) | 1.74846926 |
| 118 | Reticulocytosis (HP:0001923) | 1.72488591 |
| 119 | Hyperphosphaturia (HP:0003109) | 1.71633943 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.71443852 |
| 121 | Abnormal hand bone ossification (HP:0010660) | 1.71047586 |
| 122 | Fair hair (HP:0002286) | 1.70586949 |
| 123 | Abnormal delivery (HP:0001787) | 1.69987020 |
| 124 | Glycosuria (HP:0003076) | 1.68034938 |
| 125 | Abnormality of urine glucose concentration (HP:0011016) | 1.68034938 |
| 126 | Abnormality of the lumbar spine (HP:0100712) | 1.67277015 |
| 127 | Abnormal ossification of hand bones (HP:0005921) | 1.67013944 |
| 128 | Vaginal fistula (HP:0004320) | 1.65016304 |
| 129 | Gangrene (HP:0100758) | 1.64214271 |
| 130 | Hepatoblastoma (HP:0002884) | 1.56816653 |
| 131 | Abnormality of the nasal septum (HP:0000419) | 1.56145232 |
| 132 | Proximal tubulopathy (HP:0000114) | 1.53836003 |
| 133 | Submucous cleft hard palate (HP:0000176) | 1.53640632 |
| 134 | Increased serum ferritin (HP:0003281) | 1.51063139 |
| 135 | Mucopolysacchariduria (HP:0008155) | 1.48328810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.28589277 |
| 2 | FGFR4 | 4.63408019 |
| 3 | SIK1 | 4.53956107 |
| 4 | ERN1 | 4.35807893 |
| 5 | TAOK3 | 3.05734717 |
| 6 | WNK4 | 3.00720876 |
| 7 | INSRR | 2.96212255 |
| 8 | ERBB4 | 2.87966788 |
| 9 | CDK12 | 2.79323260 |
| 10 | PIK3CA | 2.64173663 |
| 11 | MAP2K4 | 2.35667340 |
| 12 | PKN2 | 2.27776655 |
| 13 | MST1R | 2.14848909 |
| 14 | TYRO3 | 2.07197326 |
| 15 | FGFR1 | 1.99957043 |
| 16 | FLT3 | 1.94985944 |
| 17 | MAPK11 | 1.91606941 |
| 18 | PIK3CG | 1.87626291 |
| 19 | PDGFRA | 1.87307096 |
| 20 | TRIB3 | 1.81303556 |
| 21 | TYK2 | 1.71987792 |
| 22 | AKT3 | 1.63920122 |
| 23 | LATS1 | 1.62296511 |
| 24 | EIF2AK1 | 1.58957836 |
| 25 | DAPK2 | 1.57792009 |
| 26 | ABL2 | 1.49332561 |
| 27 | PTK6 | 1.47481339 |
| 28 | NEK9 | 1.42990208 |
| 29 | WNK1 | 1.36539236 |
| 30 | FGFR2 | 1.35699271 |
| 31 | KDR | 1.35269211 |
| 32 | FRK | 1.32762429 |
| 33 | MAP3K2 | 1.32283825 |
| 34 | JAK2 | 1.23102825 |
| 35 | SIK2 | 1.16918402 |
| 36 | MAP3K7 | 1.16596026 |
| 37 | PINK1 | 1.14699681 |
| 38 | PRKAA2 | 1.11461354 |
| 39 | GRK6 | 1.10658359 |
| 40 | MAP2K3 | 1.10196134 |
| 41 | TBK1 | 1.05243840 |
| 42 | NTRK3 | 1.05065643 |
| 43 | MAP3K10 | 1.01195214 |
| 44 | ERBB2 | 1.01183775 |
| 45 | JAK1 | 1.01136470 |
| 46 | MAPK4 | 0.98983273 |
| 47 | EEF2K | 0.97675192 |
| 48 | MAP3K14 | 0.92949845 |
| 49 | PRKCZ | 0.91684428 |
| 50 | MAPKAPK3 | 0.89727663 |
| 51 | MAP3K3 | 0.88401603 |
| 52 | MET | 0.87949705 |
| 53 | DDR2 | 0.86983886 |
| 54 | STK38L | 0.84922799 |
| 55 | EPHB1 | 0.84882033 |
| 56 | MAP3K11 | 0.83225666 |
| 57 | CDK6 | 0.81778409 |
| 58 | MAPK12 | 0.81335134 |
| 59 | CSNK1E | 0.81324796 |
| 60 | TIE1 | 0.79140208 |
| 61 | SGK1 | 0.78473577 |
| 62 | MAPK15 | 0.78104167 |
| 63 | PRKACG | 0.77849100 |
| 64 | CDK7 | 0.76307714 |
| 65 | EPHA3 | 0.76059949 |
| 66 | DYRK1B | 0.71313634 |
| 67 | RPS6KB1 | 0.71284770 |
| 68 | CAMK2G | 0.71011237 |
| 69 | CSK | 0.69661243 |
| 70 | CAMK1D | 0.67637999 |
| 71 | GSK3A | 0.67572951 |
| 72 | MAP2K6 | 0.66844957 |
| 73 | KSR2 | 0.66483748 |
| 74 | PRKAA1 | 0.65172642 |
| 75 | FGR | 0.64482110 |
| 76 | BCR | 0.64332638 |
| 77 | RIPK1 | 0.60802895 |
| 78 | SGK3 | 0.60730812 |
| 79 | TGFBR2 | 0.59672562 |
| 80 | CDC42BPA | 0.58516734 |
| 81 | CSNK1D | 0.57559801 |
| 82 | CSF1R | 0.57352664 |
| 83 | BRSK2 | 0.57077271 |
| 84 | PTK2 | 0.56583670 |
| 85 | MAPK7 | 0.56438055 |
| 86 | FGFR3 | 0.55632440 |
| 87 | IRAK3 | 0.55040480 |
| 88 | NLK | 0.54290592 |
| 89 | NEK1 | 0.53358073 |
| 90 | IKBKE | 0.53300784 |
| 91 | PRKCQ | 0.51754391 |
| 92 | PDPK1 | 0.51658919 |
| 93 | PRKG1 | 0.50791969 |
| 94 | BRSK1 | 0.49155228 |
| 95 | TAOK2 | 0.47956031 |
| 96 | EPHA4 | 0.47558790 |
| 97 | CSNK1G1 | 0.47018737 |
| 98 | SRC | 0.46186324 |
| 99 | MAP3K5 | 0.45162178 |
| 100 | GRK1 | 0.45146285 |
| 101 | MAP2K1 | 0.43724332 |
| 102 | IGF1R | 0.43375781 |
| 103 | BRD4 | 0.43211791 |
| 104 | SGK2 | 0.43064464 |
| 105 | RPS6KA3 | 0.42837113 |
| 106 | CDK4 | 0.42798199 |
| 107 | RET | 0.42590262 |
| 108 | PRKCG | 0.42233384 |
| 109 | EPHA2 | 0.41148337 |
| 110 | STK39 | 0.40975602 |
| 111 | CSNK2A2 | 0.40927541 |
| 112 | SCYL2 | 0.40461931 |
| 113 | ICK | 0.39848305 |
| 114 | PBK | 0.39432282 |
| 115 | MAP3K13 | 0.38680385 |
| 116 | PKN1 | 0.38232904 |
| 117 | MAP3K6 | 0.38107729 |
| 118 | CSNK2A1 | 0.36774841 |
| 119 | FER | 0.35791986 |
| 120 | MTOR | 0.34826649 |
| 121 | EGFR | 0.34290322 |
| 122 | PDK1 | 0.33110924 |
| 123 | PRKACA | 0.33098004 |
| 124 | MATK | 0.32486737 |
| 125 | CAMK4 | 0.31884157 |
| 126 | SGK223 | 0.31441035 |
| 127 | SGK494 | 0.31441035 |
| 128 | PRKCB | 0.31385365 |
| 129 | PRKACB | 0.30341709 |
| 130 | CAMKK2 | 0.28566901 |
| 131 | NEK2 | 0.28217739 |
| 132 | MAP3K1 | 0.28015069 |
| 133 | CSNK1G2 | 0.26884818 |
| 134 | YES1 | 0.26216071 |
| 135 | MAPK3 | 0.26208219 |
| 136 | PRKCA | 0.25993391 |
| 137 | LATS2 | 0.25126286 |
| 138 | CSNK1G3 | 0.24199272 |
| 139 | PDK3 | 0.22786153 |
| 140 | PDK4 | 0.22786153 |
| 141 | MAP2K2 | 0.22286961 |
| 142 | PAK3 | 0.21663795 |
| 143 | IRAK1 | 0.21356745 |
| 144 | BMX | 0.21165237 |
| 145 | ABL1 | 0.20357505 |
| 146 | IRAK2 | 0.20217260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.52255386 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65009482 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40172904 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33590363 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08376586 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82288354 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69424789 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67187350 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64680076 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55331303 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49346180 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37891229 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22487077 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15594868 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12005917 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06632553 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94090608 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92337613 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91715913 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91405203 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88777385 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86946387 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81710976 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78318235 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74917179 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74744891 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71402615 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70373821 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69422270 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64224207 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63826279 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58002864 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56046889 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51128035 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50600021 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.47811212 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44255289 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36126922 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35404686 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35143019 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32590462 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27050897 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21688526 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20804597 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20242322 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19140521 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.18728911 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13306128 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02426279 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00389337 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99712701 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99266105 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98325325 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96367443 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95777954 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86788042 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86677090 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82577943 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80368702 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76646665 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70705668 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66755993 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64604583 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61413338 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59265003 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53949106 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46921635 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45911748 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.44764374 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39329733 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.36414564 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26270061 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26029349 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24220816 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23199905 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22539695 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.22456001 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21337387 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21210002 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15738880 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.10124252 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09537369 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01525670 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2461620 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2430110 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2403826 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2375930 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2270576 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2001477 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1953148 |
| 91 | Lysosome_Homo sapiens_hsa04142 | -0.1933781 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1863688 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1851889 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1843052 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1805665 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1609421 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1608227 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1579501 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1475614 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1398811 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1296933 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1158642 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1139028 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1045259 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0925519 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0703285 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0697487 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0410249 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0113174 |

